|
1
|
Bosetti C, Turati F and La Vecchia C:
Hepatocellular carcinoma epidemiology. Best Pract Res Clin
Gastroenterol. 28:753–770. 2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Hartke J, Johnson M and Ghabril M: The
diagnosis and treatment of hepatocellular carcinoma. Semin Diagn
Pathol. 34:153–159. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Balyasnikova S and Brown G: Optimal
imaging strategies for rectal cancer staging and ongoing
management. Curr Treat Options Oncol. 17(32)2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Yang JD, Hainaut P, Gores GJ, Amadou A,
Plymoth A and Roberts LR: A global view of hepatocellular
carcinoma: Trends, risk, prevention and management. Nat Rev
Gastroenterol Hepatol. 16:589–604. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Kye BH, Lee SH, Jeong WK, Yu CS, Park IJ,
Kim HR, Kim J, Lee IK, Park KJ, Choi HJ, et al: Which strategy is
better for resectable synchronous liver metastasis from colorectal
cancer, simultaneous surgery, or staged surgery? Multicenter
retrospective analysis. Ann Surg Treat Res. 97:184–193.
2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Lamba R, Fananapazir G, Corwin MT and
Khatri VP: Diagnostic imaging of hepatic lesions in adults. Surg
Oncol Clin N Am. 23:789–820. 2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Kim H, Mousa M, Schexnailder P,
Hergenrother R, Bolding M, Ntsikoussalabongui B, Thomas V and
Morgan DE: Portable perfusion phantom for quantitative DCE-MRI of
the abdomen. Med Phys. 44:5198–5209. 2017.PubMed/NCBI View
Article : Google Scholar
|
|
8
|
Chen BB, Hsu CY, Yu CW, Liang PC, Hsu C,
Hsu CH, Cheng AL and Shih TT: Early perfusion changes within 1 week
of systemic treatment measured by dynamic contrast-enhanced MRI may
predict survival in patients with advanced hepatocellular
carcinoma. Eur Radiol. 27:3069–3079. 2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Chouhan MD, Bainbridge A, Atkinson D,
Punwani S, Mookerjee RP, Lythgoe MF and Taylor SA: Improved hepatic
arterial fraction estimation using cardiac output correction of
arterial input functions for liver DCE MRI. Phys Med Biol.
62:1533–1546. 2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Joo I, Lee JM, Han JK, Yang HK, Lee HJ and
Choi BI: Dynamic contrast-enhanced MRI of gastric cancer:
Correlation of the perfusion parameters with pathological
prognostic factors. J Magn Reson Imaging. 41:1608–1614.
2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Lambin P, Leijenaar RTH, Deist TM,
Peerlings J, de Jong EEC, van Timmeren J, Sanduleanu S, Larue RTHM,
Even AJG, Jochems A, et al: Radiomics: The bridge between medical
imaging and personalized medicine. Nat Rev Clin Oncol. 14:749–762.
2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Huang Y, Liang C, He L, Tian J, Liang CS,
Chen X, Ma ZL and Liu ZY: Development and validation of a radiomics
nomogram for preoperative prediction of lymph node metastasis in
colorectal cancer. J Clin Oncol. 34:2157–2164. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Huang Y, Liu Z, He L, Chen X, Pan D, Ma Z
and Liang C, Tian J and Liang C: Radiomics signature: A potential
biomarker for the prediction of disease-free survival in
early-stage (I or II) non-small cell lung cancer. Radiology.
281:947–957. 2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Yang JF, Zhao ZH, Zhang Y, Zhao L, Yang
LM, Zhang MM, Wang BY, Wang T and Lu BC: Dual-input two-compartment
pharmacokinetic model of dynamic contrast-enhanced magnetic
resonance imaging in hepatocellular carcinoma. World J
Gastroenterol. 22:3652–3662. 2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Tao X, Wang L, Hui Z, Liu L, Ye F, Song Y,
Tang Y, Men Y, Lambrou T, Su Z, et al: DCE-MRI Perfusion and
permeability parameters as predictors of tumor response to CCRT in
patients with locally advanced NSCLC. Sci Rep.
6(35569)2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
R Core Team: R: A language and environment
for statistical computing. R Foundation for Statistical Computing,
Vienna, Austria, 2013.
|
|
17
|
Li J, Wang W, Xia P, Wan L, Zhang L, Yu L,
Wang L, Chen X, Xiao Y and Xu C: Identification of a five-lncRNA
signature for predicting the risk of tumor recurrence in patients
with breast cancer. Int J Cancer. 143:2150–2160. 2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Heacock L, Gao Y, Heller SL, Melsaether
AN, Babb JS, Block TK, Otazo R, Kim SG and Moy L: Comparison of
conventional DCE-MRI and a novel golden-angle radial multicoil
compressed sensing method for the evaluation of breast lesion
conspicuity. J Magn Reson Imaging. 45:1746–1752. 2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ginsburg SB, Algohary A, Pahwa S, Gulani
V, Ponsky L, Aronen HJ, Boström PJ, Böhm M, Haynes AM, Brenner P,
et al: Radiomic features for prostate cancer detection on MRI
differ between the transition and peripheral zones: Preliminary
findings from a multi-institutional study. J Magn Reson Imaging.
46:184–193. 2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Aronhime S, Calcagno C, Jajamovich GH,
Dyvorne HA, Robson P, Dieterich D, Fiel MI, Martel-Laferriere V,
Chatterji M, Rusinek H and Taouli B: DCE-MRI of the liver: Effect
of linear and nonlinear conversions on hepatic perfusion
quantification and reproducibility. J Magn Reson Imaging. 40:90–98.
2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Grossmann P, Narayan V, Chang K, Rahman R,
Abrey L, Reardon DA, Schwartz LH, Wen PY, Alexander BM, Huang R and
Aerts HJWL: Quantitative imaging biomarkers for risk stratification
of patients with recurrent glioblastoma treated with bevacizumab.
Neuro Oncol. 19:1688–1697. 2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
O'Neill AF, Qin L, Wen PY, de Groot JF,
Van den Abbeele AD and Yap JT: Demonstration of DCE-MRI as an early
pharmacodynamic biomarker of response to VEGF Trap in glioblastoma.
J Neurooncol. 130:495–503. 2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Lee SH, Hayano K, Zhu AX, Sahani DV and
Yoshida H: Dynamic contrast-enhanced MRI kinetic parameters as
prognostic biomarkers for prediction of survival of patient with
advanced hepatocellular carcinoma: A pilot comparative study. Acad
Radiol. 22:1344–1360. 2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Gandhi M, Choo SP, Thng CH, Tan SB, Low
AS, Cheow PC, Goh AS, Tay KH, Lo RH, Goh BK, et al: Single
administration of selective internal radiation therapy versus
continuous treatment with sorafeNIB in locally advanced
hepatocellular carcinoma (SIRveNIB): Study protocol for a phase III
randomized controlled trial. BMC Cancer. 16(856)2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Gaeta M, Benedetto C, Minutoli F, D'Angelo
T, Amato E, Mazziotti S, Racchiusa S, Mormina E, Blandino A and
Pergolizzi S: Use of diffusion-weighted, intravoxel incoherent
motion, and dynamic contrast-enhanced MR imaging in the assessment
of response to radiotherapy of lytic bone metastases from breast
cancer. Acad Radiol. 21:1286–1293. 2014.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Şen H, Tan YZ, Binnetoğlu E, Aşik M, Güneş
F, Erbağ G, Gazi E, Cevizci S, Özdemir S, Akbal E and Ükinç K:
Evaluation of liver perfusion in diabetic patients using 99
mTc-sestamibi. Wien Klin Wochenschr. 127:19–23. 2015.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Kusano M, Honda M, Okabayashi K, Akimaru
K, Kino S, Tsuji Y, Watanabe M, Suzuki S, Yoshikawa T, Sakamoto J,
et al: Randomized controlled phase III study comparing hepatic
arterial infusion with systemic chemotherapy after curative
resection for liver metastasis of colorectal carcinoma: JFMC
29-0003. J Cancer Res Ther. 13:84–90. 2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Avanzo M, Stancanello J and El Naqa I:
Beyond imaging: The promise of radiomics. Phys Med. 38:122–139.
2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Peeken JC, Nüsslin F and Combs SE:
‘Radio-oncomics’: The potential of radiomics in radiation oncology.
Strahlenther Onkol. 193:767–779. 2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Peeken JC, Bernhofer M, Wiestler B,
Goldberg T, Cremers D, Rost B, Wilkens JJ, Combs SE and Nüsslin F:
Radiomics in radiooncology-challenging the medical physicist. Phys
Med. 48:27–36. 2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Limkin EJ, Sun R, Dercle L, Zacharaki EI,
Robert C, Reuzé S, Schernberg A, Paragios N, Deutsch E and Ferté C:
Promises and challenges for the implementation of computational
medical imaging (radiomics) in oncology. Ann Oncol. 28:1191–1206.
2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Li Y, Liu X, Xu K, Qian Z, Wang K, Fan X,
Li S, Wang Y and Jiang T: MRI features can predict EGFR expression
in lower grade gliomas: A voxel-based radiomic analysis. Eur
Radiol. 28:356–362. 2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Li Z, Sun J, Chen L, Huang N, Hu P, Hu X,
Han G, Zhou Y, Bai W, Niu T and Yang X: Assessment of liver
fibrosis using pharmacokinetic parameters of dynamic
contrast-enhanced magnetic resonance imaging. Magn Reson Imaging.
44:98–104. 2016.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Shan QY, Hu HT, Feng ST, Peng ZP, Chen SL,
Zhou Q, Li X, Xie XY, Lu MD, Wang W and Kuang M: CT-based
peritumoral radiomics signatures to predict early recurrence in
hepatocellular carcinoma after curative tumor resection or
ablation. Cancer Imaging. 19(11)2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Khalifa F, Soliman A, El-Baz A, Abou
El-Ghar M, El-Diasty T, Gimel'farb G, Ouseph R and Dwyer AC: Models
and methods for analyzing DCE-MRI: A review. Med Phys.
41(124301)2014.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Rizzo S, Botta F, Raimondi S, Origgi D,
Fanciullo C, Morganti AG and Bellomi M: Radiomics: The facts and
the challenges of image analysis. Eur Radiol Exp.
2(36)2018.PubMed/NCBI View Article : Google Scholar
|
